Form 8-K - Current report:
SEC Accession No. 0000950170-24-137922
Filing Date
2024-12-18
Accepted
2024-12-18 16:30:06
Documents
11
Period of Report
2024-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aktx-20241212.htm   iXBRL 8-K 47472
  Complete submission text file 0000950170-24-137922.txt   270538

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aktx-20241212.xsd EX-101.SCH 97669
13 EXTRACTED XBRL INSTANCE DOCUMENT aktx-20241212_htm.xml XML 6056
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 241559653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)